Miss Arlene Vogan
Senior Specialist, Health Economics (HTA)
School of Public Health
College of Health
Arlene is a Senior Health Economist at Adelaide Health Technology Assessment (AHTA), University of Adelaide, with over a decade of experience in health economics and health technology assessment (HTA). Her research supports evidence-based reimbursement decision-making for the Pharmaceutical Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC). She has also contributed to horizon scanning briefs, ATAGI advice, and international evaluations, including for the Singapore Ministry of Health, and was a contributing author to the most recent update of the MSAC Guidelines.Since 2021, she has led the team of health economists at AHTA, overseeing a wide range of economic evaluations and methodological research and is a founding member of the working party for hOurHTA, a webinar series and community of practice focused on emerging and high-priority topics in HTA. Her work is grounded in a commitment to producing methodologically rigorous, policy-relevant analyses that inform healthcare decision-making and is dedicated to mentorship and contributing to the advancement of HTA both within Australia and internationally.Arlene's research interests include health economics, health technology assessment and evidence based medicine.
| Date | Type | Title | Institution Name | Country | Amount |
|---|---|---|---|---|---|
| 2016 | Award | Best Poster, HTAi 2016 | Health Technology Assessment International | - | - |
| 2014 | Fellowship | Society of Medical Decision Making - Health Technology Assessment Fellow | The Society of Medical Decision Making | - | - |
| Date | Institution name | Country | Title |
|---|---|---|---|
| 2011 - 2012 | University of Adelaide | Australia | Master of Health Economics and Policy |
| 2010 - 2010 | University of Adelaide | Australia | Graduate Certificate in Economics |
| 2004 - 2007 | University of Adelaide | Australia | Bachelor of Science (Honours) |
| Year | Citation |
|---|---|
| 2025 | Vogan, A., Milverton, J., Allani, P., Carter, D., Newton, S., Parsons, J., & Schubert, C. (2025). Economic evaluation of newborn bloodspot screening for sickle cell disease to inform public funding decision-making. In https://ahes.org.au/ahes-conference-2025/. Canberra. |
| 2018 | Carter, D. A., Vogan, A., & Merlin, T. (2018). The need for ethics committees and evaluation agencies in coverage with evidence development: the case of crizotinib in Australia. In Australasian Association of Bioethics and Health Law Conference. Townsville. |
| Year | Citation |
|---|---|
| 2019 | Newton, S., Kessels, S., Vogan, A., & Merlin, T. (2019). Shift From Regional To Federal Funding: Methodological Considerations. Poster session presented at the meeting of XVI Annual Meeting, Health Technology Assessment international (HTAi). Cologne, Germany. |
| 2018 | Milverton, J., Newton, S., Vogan, A., Schubert, C., & Merlin, T. (2018). Methodology to assess a predictive test for breast cancer recurrence. Poster session presented at the meeting of Abtracts of the Annual Meeting HTAi 2018. Vancouver, Canada: Health Technology Assessment international (HTAi). |
| 2018 | Vogan, A., & Schubert, C. M. (2018). A COST-UTILITY ANALYSIS OF PROSIGNA®, A 50 GENE TEST FOR PREDICTING BREAST CANCER RECURRENCE, IN THE AUSTRALIAN SETTING. Poster session presented at the meeting of VALUE IN HEALTH. ELSEVIER SCIENCE INC. DOI |
| 2017 | Vogan, A., Schubert, C., & Merlin, T. (2017). The Impact Of Treatment Timing On The Cost-Effectiveness Of Tests. Poster session presented at the meeting of the 14th Annual Health Technology Assessment international (HTAi) Conference. Rome, Italy. |
| 2016 | Vogan, A., Schubert, C., Newton, S., & Merlin, T. (2016). What are we missing by limiting the outcome of cost effectiveness analyses of diagnostic tests to cost per correct result?. Poster session presented at the meeting of the 13th Annual Health Technology Assessment international (HTAi) Conference. Tokyo, Japan. |
| 2015 | Vogan, A., Mitchell, A., Tamblyn, D., & Merlin, T. (2015). Managed Entry Schemes: Enabling Access To Oncology Drugs Under Uncertainty. Poster session presented at the meeting of the 12th Annual Health Technology Assessment international (HTAi) Conference. Oslo, Norway. |
| 2014 | Vogan, A., Schubert, C., Parsons, J., Morona, J., & Merlin, T. (2014). The impact of an imperfect diagnostic reference standard on the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes. Poster session presented at the meeting of the 11th Annual Health Technology Assessment international (HTAi) Conference. Washington D.C., USA. |
| 2014 | Vogan, A., Schubert, C., Parsons, J., Morona, J., & Merlin, T. (2014). Assessing the cost-effectiveness of HbA1c testing in the diagnosis of Type II diabetes and the impact of an imperfect diagnostic reference standard. Poster session presented at the meeting of the 36th Annual North American Meeting Society for Medical Decision Making (SMDM). Miami, USA. |
| Year | Citation |
|---|---|
| 2023 | Milverton, J., Allani, P., Carter, D., Vogan, A., Newton, S., & Parsons, J. (2023). Newborn bloodspot screening for sickle cell disease and beta thalassaemia (MSAC Application 1737). Canberra, ACT. |
| 2022 | Milverton, J., Demir, M., Carter, D., Hill, H., Parsons, J., Tamblyn, D., & Vogan, A. (2022). Genetic testing for children with hearing impairment (MSAC Application 1680). Canberra: Commonwealth of Australia. |
| 2022 | Newton, S., Vogan, A., Lett, B., Liufu, Z., & Parsons, J. (2022). Small gene panel testing for non-squamous non-small cell lung cancer (MSAC Application 1721). Canberra: Commonwealth of Australia. |
| 2022 | Newton, S., Allani, P., Salinger, K., Morona, J., Mittal, R., & Vogan, A. (2022). Whole genome sequencing of mycobacterium to identify antimicrobial-resistant pathogens (MSAC Application 1646). Canberra: Commonwealth of Australia. |
| 2020 | Tamblyn, D., Vogan, A., Parsons, J., Schubert, C., Bellman, S., & Carter, D. (2020). Technical report to supplement clinical utility card for genetic testing for diagnosis of inheritable cardiomyopathies (MSAC Application 1599). Canberra: Commonwealth of Australia. |
| 2020 | Tamblyn, D., Vogan, A., Parsons, J., Schubert, C., Bellman, S., & Carter, D. (2020). Clinical utility card for heritable cardiomyopathies. |
| 2019 | Wyndham, A., Vogan, A., Newton, S., & Schubert, C. (2019). Immunoglobulin for acquired hypogammaglobulinaemia secondary to haematological malignancies, or post-haemopoietic stem cell transplantation (MSAC application 1565). Commonwealth of Australia. |
| 2019 | Kessels, S., Newton, S., Vogan, A., Mittal, R., Schubert, C., Carter, D., . . . Merlin, T. (2019). Clinical utility card for heritable mutations associated with familial hypercholesterolaemia (MSAC Application 1534). Canberra: Commonwealth of Australia. |
| 2019 | Kessels, S., Newton, S., Vogan, A., Mittal, R., Schubert, C., Carter, D., . . . Merlin, T. (2019). Technical report to supplement clinical utility card for heritable mutations associated with familial hypercholesterolaemia (MSAC Application 1534). Canberra: Commonwealth of Australia. |
| 2018 | Mittal, R., Kessels, S., Morona, J., Newton, S., Vogan, A., & Schubert, C. (2018). Heritable mutations which increase risk in colorectal and endometrial cancer - Lynch syndrome and adenomatous polyposis syndrome. Economic and financial evaluation. (MSAC clinical utility card 1504). Canberra: Commonwealth of Australia. |
| 2018 | Milverton, J., Vogan, A., Newton, S., Parsons, J., Schubert, C., & Merlin, T. (2018). Extended half-life clotting factor concentrates for the treatment of haemophilia A and B (MSAC Application 1511). |
| 2018 | Milverton, J., Vogan, A., Parsons, J., Kessels, S., Carter, D., Schubert, C., . . . Merlin, T. (2018). Genetic deletion testing for alpha thalassaemia (MSAC Application 1531). Canberra: Commonwealth of Australia. |
| 2017 | Milverton, J., Vogan, A., Newton, S., Schubert, C., & Merlin, T. (2017). 50 gene signature assay for predicting breast cancer recurrence (MSAC Application 1473). |
| 2016 | Morona, J., Vogan, A., Kessels, S., Newton, S., Pridham, L., Ellery, B., . . . Merlin, T. (2016). Magnetic resonance imaging of patients with suspected non-ischaemic cardiomyopathies (MSAC 1432). Canberra. |
| 2016 | Morona, J., Kessels, S., Vogan, A., Mittal, R., Newton, S., Parsons, J., . . . Merlin, T. (2016). Cardiac MRI for myocardial stress perfusion and viability imaging in patients with known or suspected coronary artery disease (MSAC application number 1237). Canberra, ACT: Commonwealth of Australia. |
| 2016 | Kessels, S., Mittal, R., Morona, J., Newton, S., Ellery, B., Milverton, J., . . . Merlin, T. (2016). Magnetic resonance imaging of patients with suspected (non-ischaemic) dilated cardiomyopathies (MSAC Application no. 1393). Canberra, ACT: Commonwealth of Australia. |
| 2015 | Kessels, S., Morona, J., Mittal, R., Vogan, A., Newton, S., Schubert, C., & Merlin, T. (2015). Testing for hereditary mutations in the Cystic Fibrosis conductance Transmembrane Regulator (CFTR) gene (1216). http://www.msac.gov.au/internet/msac/publishing.nsf/Content/B1083E11E4A3006BCA257BCB0081849E/$File/1216-MSAC-CA-CFTR.pdf: Commonwealth of Australia. |
| 2014 | Ellery, B., Milverton, J., Newton, S., Morona, J. K., Gum, D., Parsons, J., . . . Merlin, T. (2014). Retinal photography with a non-mydriatic retinal camera in people with diabetes (MSAC Application number 1181). Canberra, ACT.: Commonwealth of Australia. |
| 2014 | Morona, J. K., Vogan, A., Kessels, S., Gum, D., Milverton, J., Parsons, J., . . . Merlin, T. (2014). Nucleic acid amplification testing for active mycobacterial infection (MSAC Application number 1234). Canberra, ACT.: Commonwealth of Australia. |
| 2014 | Parsons, J., Vogan, A., Morona, J. K., Schubert, C., & Merlin, T. (2014). HBA1c test for the diagnosis of diabetes mellitus (MSAC Application 1267). Canberra, ACT.: Commonwealth of Australia. |
| Date | Institution | Department | Organisation Type | Country |
|---|---|---|---|---|
| 2018 - 2023 | National Health and Medical Research Council | National Health and Medical Research Council | Health services and related | Australia |
Connect With Me
